Works about DISODIUM pamidronate

Results: 231

The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.

Published in:

2010

By:

Slobodin, Gleb;
Rosner, Itzhak;
Rimar, Doron;
Boulman, Nina;
Rozenbaum, Michael;
Odeh, Majed

Publication type:

Report

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone.

Published in:

Oncology, 2009, v. 76, n. 3, p. 209, doi. 10.1159/000201931

By:

Christodoulou, C.;
Pervena, A.;
Klouvas, G.;
Galani, E.;
Falagas, M. E.;
Tsakalos, G.;
Visvikis, A.;
Nikolakopoulou, A.;
Acholos, V.;
Karapanagiotidis, G.;
Batziou, E.;
Skarlos, D. V.

Publication type:

Article

Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2004, v. 29, n. 5, p. 431, doi. 10.1111/j.1365-2710.2004.00584.x

By:

Cauza, E.;
Etemad, M.;
Winkler, F.;
Hanusch-Enserer, H.;
Partsch, G.;
Noske, H.;
Dunky, A.

Publication type:

Article

A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.

Published in:

British Journal of Pharmacology, 2006, v. 147, n. 4, p. 437, doi. 10.1038/sj.bjp.0706628

By:

Mönkkönen, Hannu;
Auriola, Seppo;
Lehenkari, Petri;
Kellinsalmi, Maarit;
Hassinen, Ilmo E.;
Vepsäläinen, Jouko;
Mönkkönen, Jukka

Publication type:

Article

Ranolazine: Ion-channel-blocking actions and in vivo electrophysiological effects.

Published in:

British Journal of Pharmacology, 2004, v. 142, n. 8, p. 1300, doi. 10.1038/sj.bjp.0705879

By:

Schram, Gernot;
Liming Zhang;
Derakhchan, Katayoun;
Ehrlich, Joachim R.;
Belardinelli, Luiz;
Nattel, Stanley

Publication type:

Article

Nonuraemic calciphylaxis: response to treatment with pamidronate and negative pressure therapy.

Published in:

Clinical & Experimental Dermatology, 2015, v. 40, n. 1, p. 52, doi. 10.1111/ced.12505

By:

Lorriaux, A.;
Chaby, G.;
Dhaille, F.;
Dadban, A.;
Arnault, J. P.;
Dhillies, A. S.;
Lombart, F.;
Chatelain, D.;
Lok, C.

Publication type:

Article

Investigating the efficacy of pamidronate, a chemical inhibitor of farnesyl pyrophosphate synthase, in the inhibition of influenza virus infection in vitro and in vivo.

Published in:

Molecular Medicine Reports, 2014, v. 9, n. 1, p. 51, doi. 10.3892/mmr.2013.1750

By:

KAI SEN TAN;
WAI CHIING;
SEET, JUEE;
OLFAT, FARZAD;
ENGELWARD, BEVIN P.;
CHOW, VINCENT T. K.

Publication type:

Article

The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.

Published in:

European Journal of Haematology, 2012, v. 88, n. 5, p. 446, doi. 10.1111/j.1600-0609.2012.01765.x

By:

Richardson, Paul G.;
Laubach, Jacob P.;
Schlossman, Robert L.;
Ghobrial, Irene M.;
Redman, Katherine C.;
Mckenney, Mary;
Warren, Diane;
Noonan, Kimberly;
Lunde, Laura;
Doss, Deborah;
Colson, Kathleen;
Hideshima, Teru;
Mitsiades, Constantine;
Munshi, Nikhil C.;
Anderson, Kenneth C.

Publication type:

Article

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and β<sub>2</sub> -microglobulin in multiple myeloma.

Published in:

European Journal of Haematology, 2003, v. 70, n. 1, p. 34, doi. 10.1034/j.1600-0609.2003.02823.x

By:

Terpos, Evangelos;
Viniou, Nora;
de la Fuente, Josu;
Meletis, John;
Voskaridou, Ersi;
Karkantaris, Christos;
Vaiopoulos, George;
Palermos, John;
Yataganas, Xenophon;
Goldman, John M;
Rahemtulla, Amin

Publication type:

Article

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma.

Published in:

European Journal of Haematology, 2000, v. 65, n. 5, p. 331, doi. 10.1034/j.1600-0609.2000.065005331.x

By:

Terpos, Evangelos;
Palermos, John;
Tsionos, Konstantinos;
Anargyrou, Konstantinos;
Viniou, Nora;
Papassavas, Pantelis;
Meletis, John C.;
Yataganas, Xenophon

Publication type:

Article

Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise.

Published in:

Journal of Research in Medical Sciences, 2011, v. 16, n. 5, p. 703

By:

Salesi1, Mansour;
Mottaghi2, Peyman

Publication type:

Article

Insight into the Interaction Between Carbopol 940 and Ionic/Nonionic Surfactant.

Published in:

Journal of Surfactants & Detergents, 2015, v. 18, n. 3, p. 505, doi. 10.1007/s11743-015-1677-7

By:

Milanović, Maja;
Krstonošić, Veljko;
Dokić, Ljubica;
Hadnađev, Miroslav;
Dapčević Hadnađev, Tamara

Publication type:

Article

Synthesis, Characterization and Cytotoxicity Evaluation of an Oleic Acid Derived Novel Bicephalous Dianionic Surfactant.

Published in:

Journal of Surfactants & Detergents, 2015, v. 18, n. 3, p. 537, doi. 10.1007/s11743-015-1678-6

By:

Kalhapure, Rahul S.;
Akamanchi, Krishnacharya G.

Publication type:

Article

Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions.

Published in:

Developmental Neurorehabilitation, 2010, v. 13, n. 1, p. 31, doi. 10.3109/17518420903236270

By:

Howe, Warwick;
Davis, Elizabeth;
Valentine, Jane

Publication type:

Article

Incidence of serious side effects with intravenous bisphosphonate: a clinical audit.

Published in:

QJM: An International Journal of Medicine, 2012, v. 105, n. 10, p. 965, doi. 10.1093/qjmed/hcs112

By:

Powell, D.;
Bowler, C.;
Roberts, T.;
Garton, M.;
Matthews, C.;
Mccall, I.;
Davie, M.

Publication type:

Article

Primary Amino-Bisphosphonates: A New Class of Gastrotoxic Drugs--Comparison of Alendronate and Aspirin.

Published in:

American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 8, p. 1322

By:

Graham, David Y.;
Malaty, Hoda M.;
Goodgame, Richard

Publication type:

Article

Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre.

Published in:

Supportive Care in Cancer, 2013, v. 21, n. 6, p. 1557, doi. 10.1007/s00520-012-1694-2

By:

Murphy, Laura;
McCarthy, Joy;
McCrate, Farah;
Laing, Kara;
Powell, Erin;
Seal, Melanie;
Edwards, Scott

Publication type:

Article

A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis.

Published in:

European Journal of Clinical Pharmacology, 2002, v. 57, n. 12, p. 883, doi. 10.1007/s00228-001-0411-8

By:

Cremers, Serge;
Sparidans, Rolf;
den Hartigh, Jan;
Hamdy, Neveen;
Vermeij, Pieter;
Papapoulos, Socrates

Publication type:

Article

Diplopia following intravenous administration of pamidronate.

Published in:

Eye (0950-222X), 2004, v. 18, n. 1, p. 103, doi. 10.1038/sj.eye.6700542

By:

Meany, T. P. J.;
Musadiq, M.;
Corridan, P. G. J.

Publication type:

Article

A Systematic Review and Meta Analysis of Non-Randomized Interventional Studies on the Pamidronate Treatment Efficacy for Patients with Bone Fibrous Dysplasia.

Published in:

Siriraj Medical Journal, 2023, v. 75, n. 12, p. 851, doi. 10.33192/smj.v75i12.265453

By:

Widjanarko, Nicolas Daniel;
Ekaputra, Anthony;
Ang, Jessica Felicia

Publication type:

Article

Ibandronate: Its Role in Metastatic Breast Cancer.

Published in:

Oncologist, 2006, v. 11, p. 27, doi. 10.1634/theoncologist.11-90001-27

By:

Cameron, David;
Fallon, Marie;
Diel, Ingo

Publication type:

Article

The Role of Bisphosphonates in Early Breast Cancer.

Published in:

Oncologist, 2006, v. 11, p. 13, doi. 10.1634/theoncologist.11-90001-13

By:

Paterson, Alexander H.G.

Publication type:

Article

The Role of Bisphosphonates in Early Breast Cancer.

Published in:

Oncologist, 2006, v. 11, p. 13, doi. 10.1634/theoncologist.11-90001-13

By:

Paterson, Alexander H. G.

Publication type:

Article

Osteogenesis imperfecta type I: A case report.

Published in:

Experimental & Therapeutic Medicine, 2014, v. 7, n. 6, p. 1535, doi. 10.3892/etm.2014.1653

By:

JIANMIN REN;
XIAOJIE XU;
XIANGDONG JIAN;
JIERU WANG

Publication type:

Article

Nephrotic syndrome induced by pamidronate.

Published in:

2011

By:

ten Dam, M.;
Hilbrands, L.;
Wetzels, J.;
ten Dam, M A G J;
Hilbrands, L B;
Wetzels, J F M

Publication type:

journal article

Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts.

Published in:

Human & Experimental Toxicology, 2015, v. 34, n. 11, p. 1073, doi. 10.1177/0960327115569808

By:

Soydan, S. S.;
Araz, K.;
Senel, F. V.;
Yurtcu, E.;
Helvacioglu, F.;
Dagdeviren, A.;
Tekindal, M. A.;
Sahin, F.

Publication type:

Article

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study.

Published in:

Leukemia & Lymphoma, 2011, v. 52, n. 5, p. 771, doi. 10.3109/10428194.2011.553000

By:

D'arena, Giovanni;
Gobbi, Paolo G.;
Broglia, Chiara;
Sacchi, Stefano;
Quarta, Giovanni;
Baldini, Luca;
Iannitto, Emilio;
Falcone, Antonietta;
Guariglia, Roberto;
Pietrantuono, Giuseppe;
Villani, Oreste;
Martorelli, Maria Carmen;
Mansueto, Giovanna;
Sanpaolo, Grazia;
Cascavilla, Nicola;
Musto, Pellegrino

Publication type:

Article

The role of bisphosphonate therapy in the global management of multiple myeloma.

Published in:

Leukemia & Lymphoma, 2011, v. 52, n. 5, p. 736, doi. 10.3109/10428194.2011.554586

By:

Gertz, Morie A.

Publication type:

Article

Anti-tumor Activity of Pamidronate in Human Multiple Myeloma.

Published in:

Leukemia & Lymphoma, 2002, v. 43, n. 4, p. 919, doi. 10.1080/10428190290017123

By:

Kondo, Haruli;
Mori, Akinori

Publication type:

Article

Efecto de la modalidad de diálisis y otros factores de prescripción sobre las pérdidas proteicas peritoneales en diálisis peritoneal.

Published in:

Nefrologia, 2012, v. 32, n. 6, p. 782, doi. 10.3265/Nefrologia.pre2012.Jul.11465

By:

Rodríguez-Carmona, Ana;
Pérez-Fontán, Miguel;
Pértega-Díaz, Sonia;
López-Calviño, Beatriz;
López-Muñiz, Andrés;
García-Falcón, Teresa

Publication type:

Article

EFECTO DE UNA SOLA DOSIS DE ACIDO ZOLEDRONICO EN UN CASO DE ENFERMEDAD DE PAGET OSEA.

Published in:

2010

By:

Saban, Melina;
Fidalgo, Silvina;
Diaz, Carlos A.;
Lutfi, Ruben J.

Publication type:

Case Study

Low-energy conformers of pamidronate and their intramolecular hydrogen bonds: a DFT and QTAIM study.

Published in:

Journal of Molecular Modeling, 2013, v. 19, n. 1, p. 427, doi. 10.1007/s00894-012-1564-3

By:

Arabieh, Masoud;
Karimi-Jafari, Mohammad;
Ghannadi-Maragheh, Mohammad

Publication type:

Article

HPLC Method Validation and Pharmacokinetic Study of Alendronate Sodium in Human Urine with Fluorescence Detection.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2006, v. 29, n. 11, p. 1589, doi. 10.1080/10826070600678308

By:

Kang, Hyun‐Suk;
Hwang, Sung‐Joo;
Park, Jeong‐Sook;
Kim, Chong‐Kook

Publication type:

Article

Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial.

Published in:

2015

By:

Mok, CC;
Li, OC;
Chan, KL;
Ho, LY;
Hui, PK

Publication type:

journal article

Hermes.

Published in:: Pediatric Radiology, 2014, v. 44, n. 5, p. 632, doi. 10.1007/s00247-014-2879-2
Publication type:: Article

Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.

Published in:

Pediatric Radiology, 2014, v. 44, n. 1, p. 115, doi. 10.1007/s00247-013-2738-6

By:

Martillotti, Jared;
Moote, Douglas;
Zemel, Lawrence

Publication type:

Article

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1137, doi. 10.1007/s00280-010-1420-z

By:

Joerger, M.;
Templeton, A.;
Köberle, D.;
Engler, H.;
Riesen, W.;
Thürlimann, B.

Publication type:

Article

Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 1, p. 165, doi. 10.1007/s00280-008-0710-1

By:

Silva, Karina Lani;
Vasconcellos, Deborah Vidal;
de Paula Castro, Eric Delfraro;
da Vasconcelos, Flavia;
Bigni, Ricardo;
Maia, Raquel Ciuvalschi

Publication type:

Article

Regulation of macrophage immune responses by antipsychotic drugs.

Published in:

Immunopharmacology & Immunotoxicology, 2013, v. 35, n. 5, p. 573, doi. 10.3109/08923973.2013.828744

By:

Chen, Mao-Liang;
Wu, Semon;
Tsai, Tzung-Chieh;
Wang, Lu-Kai;
Tsai, Fu-Ming

Publication type:

Article

Pathophysiology of Osteonecrosis of the Jaw in Patients Treated with Bisphosphonate.

Published in:

Collegium Antropologicum, 2013, v. 37, n. 2, p. 645

By:

Badel, Tomislav;
Pavičin, Ivana Savić;
Carek, Andreja Jelinić;
Rošin-Grget, Kata;
Grbeša, Ðurdica

Publication type:

Article

Safety labeling updates & new warnings.

Published in:: Formulary, 2002, v. 37, n. 11, p. 564
Publication type:: Article

Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome.

Published in:

Nephrology, 2007, v. 12, n. 4, p. 386, doi. 10.1111/j.1440-1797.2007.00806.x

By:

DAVENPORT, ANDREW;
STEARNS, MICHAEL P

Publication type:

Article

Combination treatment of bisphosphonate (pamidronate) and Quercus infectoria semi- purified fraction promotes proliferation and differentiation of osteoblast cell via expression of Osterix and Runx2 marker.

Published in:

Asian Pacific Journal of Tropical Biomedicine, 2018, v. 8, n. 5, p. 261, doi. 10.4103/2221-1691.233007

By:

Raudhah, Abdullah;
Hermizi, Hapidin;
Hasmah, Abdullah

Publication type:

Article

Treatment of Polyostotic Fibrous Dysplasia of the Thoracic Spine with Intravenous Pamidronate: Result from 9 Months Follow Up.

Published in:

2015

By:

Jongjoo Lee;
Hyunchul Shin;
Young-Jun Kwon

Publication type:

Case Study

Pharmacokinetic Considerations in Determining the Terminal Elimination Half-Lives of Bisphosphonates.

Published in:

Clinical Drug Investigation, 2005, v. 25, n. 2, p. 107, doi. 10.2165/00044011-200525020-00003

By:

Lasseter, Kenneth C.;
Porras, Arturo G.;
Denker, Andrew;
Santhanagopal, Anu;
Daifotis, Anastasia

Publication type:

Article

Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 3, p. 615, doi. 10.3109/10428194.2014.924117

By:

Sanfilippo, K. M.;
Gage, B.;
Luo, S.;
Weilbaecher, K.;
Tomasson, M.;
Vij, R.;
Colditz, G.;
Carson, K.

Publication type:

Article

Pain from osteoporotic fractures: rationale of therapeutic options.

Published in:

Clinical Cases in Mineral & Bone Metabolism, 2018, v. 15, n. 1, p. 36

By:

Kress, Hans G.

Publication type:

Article

Neonatal severe hyperparathyroidism secondary to a novel homozygous CASR gene mutation.

Published in:

2017

By:

Ahmad, Noman;
Bahasan, Mona;
Abdullah Al-Ghamdi, Balgees Abdulhadi;
Al-Enizi, Halah Faleh;
Al-Zahrani, Ali Saeed

Publication type:

Case Study

The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta.

Published in:

Hormone Research in Paediatrics, 2015, v. 83, n. 3, p. 183, doi. 10.1159/000369582

By:

Biggin, andrew;
Zheng, Linda;
Briody, Julie N.;
Coorey, Craig P.;
Munns, Craig F.

Publication type:

Article

Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age.

Published in:

Hormone Research in Paediatrics, 2013, v. 79, n. 6, p. 333, doi. 10.1159/000351374

By:

alcausin, M.B.;
Briody, J.;
Pacey, V.;
ault, J.;
McQuade, M.;
Bridge, C.;
Engelbert, R.H.H.;
Sillence, D.O.;
Munns, C.F.

Publication type:

Article